News

The trial (Freedom-301), a multi-center, randomized, double-blind, placebo-controlled Phase 3 trial designed to evaluate the safety and efficacy of Levadex as a potential treatment for acute migraine. Primary

Thomas F. Kirk, President and CEO of Hanger Orthopedic Group, said: we are very pleased to welcome the talented professionals from both Northwest and Inline to the Hanger

Protopic ointment is licensed to teat severe eczema (atopic dermatitis), and approved for twice-weekly application by the patients. Protopic ointment’s approval was based on the data demonstrated by

OCI is a technology company engaged in the design, development, manufacturing, marketing and distribution of medical electronic devices and medical monitoring products employing sensing and detection techniques. The

The company plans to file for marketing approvals worldwide under the trademarks ellaOne and ella, and continue to research pharmaceutical developments in the field of reproductive health that

New retractable designs deal with caregiver preferences while reducing part counts and manufacturing steps. These refinements are help out to close the price gap with naked disposable syringes

Under the terms of the agreement, Meiji Seika will have exclusive rights to develop and commercialize the product in Japan and several other Asian countries. ACADIA retains the

The new manufacturing plant is expected to be completed by 2012. The company will target Asian eye care market for diseases like glaucoma, eye infections, eye inflammation and

These wireless devices automatically send physicians stats that people already measure – weight, blood pressure, etc. – so doctors can intervene at the first sign of trouble rather